GO:0045159 | myosin II binding | 1.93% (4/207) | 7.55 | 0.0 | 4e-06 |
GO:0051046 | regulation of secretion | 1.93% (4/207) | 7.0 | 0.0 | 5e-06 |
GO:1903530 | regulation of secretion by cell | 1.93% (4/207) | 7.0 | 0.0 | 5e-06 |
GO:0017157 | regulation of exocytosis | 1.93% (4/207) | 7.01 | 0.0 | 1e-05 |
GO:0060627 | regulation of vesicle-mediated transport | 1.93% (4/207) | 6.27 | 0.0 | 2.6e-05 |
GO:0017022 | myosin binding | 1.93% (4/207) | 6.3 | 0.0 | 2.8e-05 |
GO:0030014 | CCR4-NOT complex | 1.93% (4/207) | 5.82 | 1e-06 | 7.8e-05 |
GO:0051049 | regulation of transport | 1.93% (4/207) | 5.66 | 1e-06 | 0.000103 |
GO:0019905 | syntaxin binding | 1.93% (4/207) | 5.39 | 3e-06 | 0.000192 |
GO:0032879 | regulation of localization | 1.93% (4/207) | 5.01 | 9e-06 | 0.000497 |
GO:0034249 | negative regulation of amide metabolic process | 1.93% (4/207) | 4.66 | 2.2e-05 | 0.000839 |
GO:0017148 | negative regulation of translation | 1.93% (4/207) | 4.66 | 2.2e-05 | 0.000839 |
GO:0006417 | regulation of translation | 2.42% (5/207) | 4.01 | 1.8e-05 | 0.000848 |
GO:0034248 | regulation of amide metabolic process | 2.42% (5/207) | 4.01 | 1.8e-05 | 0.000848 |
GO:1901616 | organic hydroxy compound catabolic process | 1.45% (3/207) | 5.88 | 2.1e-05 | 0.000909 |
GO:0090304 | nucleic acid metabolic process | 10.63% (22/207) | 1.41 | 3.4e-05 | 0.001216 |
GO:0015074 | DNA integration | 3.38% (7/207) | 2.94 | 4.3e-05 | 0.001461 |
GO:0030015 | CCR4-NOT core complex | 1.45% (3/207) | 5.36 | 6e-05 | 0.00191 |
GO:0051248 | negative regulation of protein metabolic process | 1.93% (4/207) | 4.21 | 7.5e-05 | 0.002259 |
GO:0000149 | SNARE binding | 1.93% (4/207) | 3.92 | 0.000158 | 0.004535 |
GO:0005096 | GTPase activator activity | 1.93% (4/207) | 3.86 | 0.000185 | 0.005071 |
GO:0004371 | glycerone kinase activity | 0.97% (2/207) | 6.33 | 0.000297 | 0.007764 |
GO:0006139 | nucleobase-containing compound metabolic process | 10.63% (22/207) | 1.18 | 0.000335 | 0.008385 |
GO:0019405 | alditol catabolic process | 0.97% (2/207) | 6.08 | 0.000423 | 0.009364 |
GO:0010608 | post-transcriptional regulation of gene expression | 2.42% (5/207) | 3.04 | 0.000396 | 0.009476 |
GO:0019563 | glycerol catabolic process | 0.97% (2/207) | 6.09 | 0.000414 | 0.009515 |
GO:0006725 | cellular aromatic compound metabolic process | 11.11% (23/207) | 1.11 | 0.000473 | 0.010079 |
GO:0046174 | polyol catabolic process | 0.97% (2/207) | 5.85 | 0.000583 | 0.011974 |
GO:0006402 | mRNA catabolic process | 1.93% (4/207) | 3.4 | 0.000612 | 0.01213 |
GO:0046164 | alcohol catabolic process | 0.97% (2/207) | 5.78 | 0.000642 | 0.012301 |
GO:1901360 | organic cyclic compound metabolic process | 11.11% (23/207) | 1.07 | 0.000701 | 0.012994 |
GO:0034641 | cellular nitrogen compound metabolic process | 11.11% (23/207) | 1.06 | 0.00078 | 0.014023 |
GO:0046483 | heterocycle metabolic process | 10.63% (22/207) | 1.08 | 0.000834 | 0.014528 |
GO:0000932 | P-body | 1.45% (3/207) | 4.02 | 0.000903 | 0.014834 |
GO:0005643 | nuclear pore | 1.45% (3/207) | 4.03 | 0.000884 | 0.014946 |
GO:0030695 | GTPase regulator activity | 1.93% (4/207) | 3.22 | 0.000973 | 0.015126 |
GO:0060589 | nucleoside-triphosphatase regulator activity | 1.93% (4/207) | 3.22 | 0.000973 | 0.015126 |
GO:0051246 | regulation of protein metabolic process | 2.42% (5/207) | 2.71 | 0.001108 | 0.016759 |
GO:0006401 | RNA catabolic process | 1.93% (4/207) | 3.16 | 0.001141 | 0.016817 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.45% (3/207) | 3.85 | 0.001252 | 0.018 |
GO:0035770 | ribonucleoprotein granule | 1.45% (3/207) | 3.83 | 0.001306 | 0.01832 |
GO:0008092 | cytoskeletal protein binding | 2.9% (6/207) | 2.28 | 0.00166 | 0.022732 |
GO:0016070 | RNA metabolic process | 6.28% (13/207) | 1.37 | 0.001807 | 0.024167 |
GO:0008047 | enzyme activator activity | 1.93% (4/207) | 2.95 | 0.001919 | 0.025076 |
GO:0019400 | alditol metabolic process | 0.97% (2/207) | 4.88 | 0.002181 | 0.027263 |
GO:0006071 | glycerol metabolic process | 0.97% (2/207) | 4.89 | 0.002159 | 0.027593 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 1.93% (4/207) | 2.85 | 0.002491 | 0.028646 |
GO:0140677 | molecular function activator activity | 1.93% (4/207) | 2.86 | 0.002393 | 0.028664 |
GO:0031122 | cytoplasmic microtubule organization | 0.97% (2/207) | 4.8 | 0.002449 | 0.028738 |
GO:0008380 | RNA splicing | 1.93% (4/207) | 2.87 | 0.002371 | 0.029012 |
GO:1902000 | homogentisate catabolic process | 0.48% (1/207) | 8.33 | 0.003096 | 0.033588 |
GO:1901999 | homogentisate metabolic process | 0.48% (1/207) | 8.33 | 0.003096 | 0.033588 |
GO:0008270 | zinc ion binding | 3.86% (8/207) | 1.75 | 0.002998 | 0.033804 |
GO:0004334 | fumarylacetoacetase activity | 0.48% (1/207) | 8.18 | 0.003439 | 0.035315 |
GO:0003923 | GPI-anchor transamidase activity | 0.48% (1/207) | 8.18 | 0.003439 | 0.035315 |
GO:0019336 | phenol-containing compound catabolic process | 0.48% (1/207) | 8.18 | 0.003439 | 0.035315 |
GO:0032991 | protein-containing complex | 9.18% (19/207) | 0.99 | 0.003755 | 0.037877 |
GO:0019439 | aromatic compound catabolic process | 2.42% (5/207) | 2.29 | 0.003908 | 0.038747 |
GO:1901361 | organic cyclic compound catabolic process | 2.42% (5/207) | 2.26 | 0.004202 | 0.040956 |
GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 0.48% (1/207) | 7.7 | 0.004812 | 0.046113 |